Dagmar Rosa-bjorkeson - Net Worth and Insider Trading

Dagmar Rosa-bjorkeson Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Dagmar Rosa-bjorkeson owns 5 companies in total, including Xencor Inc (XNCR) , Mallinckrodt PLC (MNKKQ) , and Baxalta Inc (BXLT) among others .

Click here to see the complete history of Dagmar Rosa-bjorkeson’s form 4 insider trades.

Insider Ownership Summary of Dagmar Rosa-bjorkeson

Ticker	Comapny	Transaction Date	Type of Owner
XNCR	Xencor Inc	2022-06-23	director
MNKKQ	Mallinckrodt PLC	2018-04-18	Chief Strat & Corp Dev Officer
BXLT	Baxalta Inc	2016-06-03	EVP and President & Biosimilars
ICPT	Intercept Pharmaceuticals Inc	2021-04-01	director
MNK	Mallinckrodt PLC	2018-04-18	Chief Strat & Corp Dev Officer

Dagmar Rosa-bjorkeson Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Dagmar Rosa-bjorkeson Ownership Network

Ownership Network List of Dagmar Rosa-bjorkeson

No Data

Ownership Network Relation of Dagmar Rosa-bjorkeson

Dagmar Rosa-bjorkeson Owned Company Details

What does Xencor Inc do?

Xencor Inc is a clinical-stage biopharmaceutical company based in the United States. It focuses on discovering and developing engineered monoclonal antibody and other protein therapeutics to treat severe and life-threatening diseases with unmet medical needs. The company uses its XmAb technology platform to create antibody product candidates such as XmAb5871 and XmAb7195. It also has a few pre-clinical stage candidates in its portfolio such as XmAb14045 and XmAb13676. It earns its revenue from research and development collaborations and licenses of its internally developed drug candidates.

Who are the key executives at Xencor Inc?

Dagmar Rosa-bjorkeson is the director of Xencor Inc. Other key executives at Xencor Inc include director & PRESIDENT & CEO Bassil I Dahiyat , SR. VICE PRESIDENT & CSO John R Desjarlais , and VP & GENERAL COUNSEL Celia Eckert .

Xencor Inc (XNCR) Insider Trades Summary

Over the past 18 months, Dagmar Rosa-bjorkeson made no insider transaction in Xencor Inc (XNCR). Other recent insider transactions involving Xencor Inc (XNCR) include a net sale of 16,707 shares made by Bassil I Dahiyat , a net sale of 13,764 shares made by Allen Yang , and a net sale of 9,069 shares made by John R Desjarlais .

In summary, during the past 3 months, insiders sold 31,108 shares of Xencor Inc (XNCR) in total and bought 0 shares, with a net sale of 31,108 shares. During the past 18 months, 50,445 shares of Xencor Inc (XNCR) were sold and 0 shares were bought by its insiders, resulting in a net sale of 50,445 shares.

Xencor Inc (XNCR)'s detailed insider trading history can be found in Insider Trading Tracker table.

Xencor Inc Insider Transactions

No Available Data

What does Mallinckrodt PLC do?

Mallinckrodt PLC develops, manufactures, markets, and distributes specialty pharmaceutical products and therapies. Its areas of focus include autoimmune and rare diseases in specialty areas like neurology, rheumatology, nephrology, pulmonology and ophthalmology; immunotherapy and neonatal respiratory critical care therapies; analgesics and gastrointestinal products. The company operates its business in two reportable segments namely Specialty Brands which include specialty pharmaceutical brands; and Specialty Generics which includes niche specialty generic drugs and active pharmaceutical ingredients. It generates maximum revenue from the Specialty Brands segment. Geographically, it derives a majority of its revenue from the United States.

Who are the key executives at Mallinckrodt PLC?

Dagmar Rosa-bjorkeson is the Chief Strat & Corp Dev Officer of Mallinckrodt PLC. Other key executives at Mallinckrodt PLC include director & President and CEO Sigurdur O Olafsson , EVP & Chief Sci. Ofcr Steven J. Romano , and 10 percent owner Fyi S.a R.l. .

Mallinckrodt PLC (MNKKQ) Insider Trades Summary

Over the past 18 months, Dagmar Rosa-bjorkeson made no insider transaction in Mallinckrodt PLC (MNKKQ). Other recent insider transactions involving Mallinckrodt PLC (MNKKQ) include a net sale of 34,065 shares made by Joann A Reed ,

In summary, during the past 3 months, insiders sold 0 shares of Mallinckrodt PLC (MNKKQ) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 34,065 shares of Mallinckrodt PLC (MNKKQ) were sold and 0 shares were bought by its insiders, resulting in a net sale of 34,065 shares.

Mallinckrodt PLC (MNKKQ)'s detailed insider trading history can be found in Insider Trading Tracker table.

Mallinckrodt PLC Insider Transactions

No Available Data

What does Baxalta Inc do?

Baxalta Inc was incorporated on September 8, 2016. It is a biopharmaceutical company engaged in the field of unmet medical needs covering various diseases which includes haemophilia, immunology and oncology. The Company develops, manufactures and markets a diverse portfolio of treatments for hemophilia and other bleeding disorders, immune deficiencies, alpha-1 antitrypsin deficiency, burns and shock, and other chronic and acute medical conditions, as well as oncology treatments for acute lymphoblastic leukemia. It also invests in emerging technology platforms, including gene therapy and biosimilars. Its competitors include Advate, Feiba, Gammagard. The Company is subject to rules and regulations put forth by the jurisdiction it operates in.

Who are the key executives at Baxalta Inc?

Dagmar Rosa-bjorkeson is the EVP and President & Biosimilars of Baxalta Inc. Other key executives at Baxalta Inc include EVP & Head of Human Resources Anne-marie Law , EVP and President & Hematology Brian Goff , and See Remarks John J Orloff .

Baxalta Inc (BXLT) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Baxalta Inc (BXLT) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Baxalta Inc (BXLT) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Baxalta Inc (BXLT)'s detailed insider trading history can be found in Insider Trading Tracker table.

Baxalta Inc Insider Transactions

No Available Data

What does Intercept Pharmaceuticals Inc do?

Intercept Pharmaceuticals Inc is a biotech company focused on developing and commercializing novel therapeutics to treat progressive non-viral liver diseases. Obeticholic acid, or OCA, is an agonist of the farnesoid X receptor. OCA was approved as Ocaliva to treat primary biliary cirrhosis in 2016 and is being developed for a variety of chronic liver diseases, including nonalcoholic steatohepatitis, or NASH.

Who are the key executives at Intercept Pharmaceuticals Inc?

Dagmar Rosa-bjorkeson is the director of Intercept Pharmaceuticals Inc. Other key executives at Intercept Pharmaceuticals Inc include EVP & Chief Financial Officer Andrew Saik , President & R&D and CMO M Michelle Berrey , and Chief Accounting Officer Rocco Venezia .

Intercept Pharmaceuticals Inc (ICPT) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Intercept Pharmaceuticals Inc (ICPT) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Intercept Pharmaceuticals Inc (ICPT) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Intercept Pharmaceuticals Inc (ICPT)'s detailed insider trading history can be found in Insider Trading Tracker table.

Intercept Pharmaceuticals Inc Insider Transactions

No Available Data

What does Mallinckrodt PLC do?

Who are the key executives at Mallinckrodt PLC?

Dagmar Rosa-bjorkeson is the Chief Strat & Corp Dev Officer of Mallinckrodt PLC. Other key executives at Mallinckrodt PLC include EVP & Chief Scientific Officer Peter C Richardson , EVP & Chief Commercial Officer Lisa French , and EVP & Head of Corp Development Jason Daniel Goodson .

Mallinckrodt PLC (MNK) Insider Trades Summary

Over the past 18 months, Dagmar Rosa-bjorkeson made no insider transaction in Mallinckrodt PLC (MNK). Other recent insider transactions involving Mallinckrodt PLC (MNK) include a net purchase of 30,000 shares made by James R Sulat , a net purchase of 5,000 shares made by Paul Bisaro , and a net purchase of 3,000 shares made by Sigurdur O Olafsson .

In summary, during the past 3 months, insiders sold 0 shares of Mallinckrodt PLC (MNK) in total and bought 40,133 shares, with a net purchase of 40,133 shares. During the past 18 months, 0 shares of Mallinckrodt PLC (MNK) were sold and 40,133 shares were bought by its insiders, resulting in a net purchase of 40,133 shares.

Mallinckrodt PLC (MNK)'s detailed insider trading history can be found in Insider Trading Tracker table.

Mallinckrodt PLC Insider Transactions

No Available Data

Dagmar Rosa-bjorkeson Mailing Address

Above is the net worth, insider trading, and ownership report for Dagmar Rosa-bjorkeson. You might contact Dagmar Rosa-bjorkeson via mailing address: C/o Baxalta Incorporated, 1200 Lakeside Drive, Bannockburn Il 60015.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Buffett Assets Allocation

Company

About GuruFocus Career Contact Us ETF ADV Part 2A ADV Part 2B ADV Part 3 Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.